ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

POLX Polarean Imaging Plc

3.75
-0.10 (-2.60%)
Last Updated: 12:12:34
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Polarean Imaging Plc LSE:POLX London Ordinary Share GB00BF3DT583 ORD GBP0.00037
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -2.60% 3.75 3.70 3.80 3.85 3.75 3.85 284,505 12:12:34
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 1.03M -13.91M -0.0644 -0.60 8.31M

Polarean Imaging PLC Comment re: share purchase (6114Z)

15/01/2024 7:00am

UK Regulatory


Polarean Imaging (LSE:POLX)
Historical Stock Chart


From Oct 2023 to Apr 2024

Click Here for more Polarean Imaging Charts.

TIDMPOLX

RNS Number : 6114Z

Polarean Imaging PLC

15 January 2024

Polarean Imaging Plc

("Polarean" or the "Company")

Comment re: share purchase

Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in advanced magnetic resonance imaging ("MRI") of the lungs, notes the TR-1 announcements released on 12 January 2024 showing the sale of 9.5 million Polarean shares held by Amati Global Investors Ltd to NUKEM Isotopes GmbH ("NUKEM Isotopes"), a strategic partner and investor in the Company. This transaction highlights the significant support NUKEM Isotopes has in Polarean, and has increased NUKEM Isotopes's Polarean holding to 10.458%.

NUKEM Isotopes GmbH is a leading trading company for stable isotopes used in different fields for various applications. They have established reliable partnerships with gas manufacturers for the production of highly pure noble gases. The company is located in Alzenau, Germany.

Enquiries :

 
  Polarean Imaging plc                                          www.polarean.com / www.polarean-ir.com 
  Christopher von Jako, Ph.D, Chief                                                    Via Walbrook PR 
   Executive Officer 
  Charles Osborne, Chief Financial 
   Officer 
 
  Stifel Nicolaus Europe Limited (NOMAD and 
   Sole Corporate Broker)                                                          +44 (0)20 7710 7600 
  Nicholas Moore / Samira Essebiyea / Kate Hanshaw (Healthcare 
   Investment Banking) 
  Nick Adams / Nick Harland (Corporate Broking) 
 
  Walbrook PR                                      Tel: +44 (0)20 7933 8780 or polarean@walbrookpr.com 
  Anna Dunphy / Phillip Marriage                                Mob: +44 (0)7876 741 001 / +44 (0)7867 
                                                                                               984 082 
 
 

About Polarean (www.polarean.com)

The Company and its wholly-owned U.S. subsidiary, Polarean, Inc. are revenue-generating, medical imaging technology companies. The Company aspires to revolutionise pulmonary medicine by bringing the power and safety of MRI to the respiratory healthcare community which is desperately in need of new modern solutions to evaluate lung function. Polarean is dedicated to researching, developing, and commercialising these novel imaging solutions with their non-invasive and radiation-free functional MRI platform. The Company strives to address the global unmet medical needs of more than 500 million patients worldwide suffering from chronic respiratory disease. Polarean is a leader in the field of hyperpolarisation science and has successfully developed the first and only hyperpolarised Xenon MRI contrast agent (XENOVIEW(TM)) to be FDA-approved in the United States. The Company also commercialises the systems, software, and accessories to support fully integrated modern respiratory imaging operations. Founded in 2012, with offices in Durham, NC, and London, United Kingdom, Polarean is committed to increasing global awareness of and broad access to its XENOVIEW MRI technology platform. For the latest news and information about Polarean, please visit www.polarean.com .

PLC-RNS-2326

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCZZGMMMDKGDZM

(END) Dow Jones Newswires

January 15, 2024 02:00 ET (07:00 GMT)

1 Year Polarean Imaging Chart

1 Year Polarean Imaging Chart

1 Month Polarean Imaging Chart

1 Month Polarean Imaging Chart

Your Recent History

Delayed Upgrade Clock